Prescription Required
Formulation: Tablet
(Brand Option)
Select the prescribed dosage
Select the quantity to see the price.
Prescription Required
Formulation: Tablet
(Generic Alternative)
Select the prescribed dosage
Select the quantity to see the price.
* This price includes a dispensing fee, medical review fee, and packing fee.
Shipped and delivered directly to your doorstep
Fosamax Plus D (alendronate sodium and vitamin D3) is a prescription medication used to treat osteoporosis in postmenopausal women and men.
Osteoporosis is a condition that causes bones to become weak, thin, and more likely to break. It develops when the body loses bone tissue faster than it can replace it.
Fosamax Plus D contains two active ingredients that work together to support bone health:
Fosamax Plus D is available as a once-weekly oral tablet containing 70 mg of alendronate sodium combined with either 2,800 or 5,600 international units (IU) of vitamin D3.
The medication helps strengthen bones over time and reduce the risk of fractures associated with osteoporosis.
Your healthcare provider will determine whether Fosamax Plus D is appropriate based on your bone mineral density, fracture risk, calcium and vitamin D levels, and medical history.Â
Fosamax Plus D is used to treat osteoporosis in women who have gone through menopause.
After menopause, estrogen levels decline significantly. Estrogen plays an important role in maintaining bone strength by helping regulate the balance between bone breakdown and bone formation.
When estrogen levels decrease, the body may begin losing bone tissue more quickly.
Over time, this can cause bones to become less dense, weaker, and more likely to fracture.
Postmenopausal osteoporosis commonly affects the spine, hips, and wrists.
Fosamax Plus D helps slow bone loss and improve bone mineral density, reducing the likelihood of certain osteoporosis-related fractures.
The medication provides several benefits:
Osteoporosis often develops without noticeable symptoms until a bone fracture occurs.
Some women may experience height loss, changes in posture, or back pain caused by vertebral fractures.
Fosamax Plus D does not immediately repair fractures or eliminate the risk of future injuries. Instead, it helps improve bone strength over time.
Your healthcare provider may recommend bone density testing, calcium intake assessment, and periodic treatment reviews to evaluate your response.
Fosamax Plus D is also prescribed to increase bone mass in men with osteoporosis.
Although osteoporosis is more common in women after menopause, men can also develop reduced bone density and experience fractures.
Bone loss in men may be associated with aging, low testosterone levels, certain medical conditions, prolonged use of specific medications, or inadequate calcium and vitamin D intake.
As bone density decreases, bones become more fragile and vulnerable to fractures.
Osteoporosis in men commonly affects the spine, hips, and other weight-bearing bones.
Fosamax Plus D helps reduce excessive bone breakdown while supporting calcium absorption.
Potential treatment benefits include:
Your healthcare provider may recommend Fosamax Plus D if bone density testing confirms osteoporosis or if your medical history indicates an increased fracture risk.
Treatment may also include adequate calcium intake, weight-bearing exercise, and addressing medical conditions that contribute to bone loss.
Long-term treatment with corticosteroid medications may increase the risk of osteoporosis.
Corticosteroids, also called glucocorticoids, are medications used to treat inflammation and certain immune-related conditions.
Examples include prednisone, prednisolone, and dexamethasone.
Although these medications can help manage many medical conditions, prolonged use may interfere with normal bone metabolism.
Glucocorticoids can reduce the activity of bone-forming cells, increase bone breakdown, and interfere with calcium balance.
As a result, people taking corticosteroids for extended periods may experience reduced bone mineral density and an increased risk of fractures.
Possible effects include:
Alendronate, one of the active ingredients in Fosamax Plus D, is approved in certain formulations for the treatment and prevention of glucocorticoid-induced osteoporosis.
However, Fosamax Plus D itself is not specifically approved for glucocorticoid-induced osteoporosis under its U.S. prescribing information.
Your healthcare provider may consider other alendronate formulations or different osteoporosis medications if you develop bone loss associated with long-term corticosteroid use.Â
Fosamax Plus D contains two active ingredients, alendronate sodium and vitamin D3, which support bone health through different mechanisms.
Bones are living tissues that continuously undergo a natural process called bone remodeling.
During bone remodeling, older bone tissue is broken down and replaced with new bone tissue.
Two important types of bone cells control this process:
In healthy bones, these processes remain relatively balanced.
However, osteoporosis develops when bone breakdown occurs faster than new bone can be formed.
Fosamax Plus D helps address this imbalance by reducing excessive bone resorption and supporting calcium absorption.
Slows Bone Breakdown
Alendronate belongs to a class of medications called bisphosphonates.
Bisphosphonates attach to mineral surfaces within bones, particularly in areas undergoing active bone remodeling.
When osteoclasts begin breaking down bone tissue, they absorb alendronate from the bone surface.
Alendronate interferes with an enzyme called farnesyl pyrophosphate synthase, which is involved in the normal function and survival of osteoclasts.
This reduces osteoclast activity and slows the breakdown of bone tissue.
As bone resorption decreases, the body can retain more of its existing bone mass.
Helps Increase Bone Mineral Density
Bone mineral density describes the amount of mineral present in a particular area of bone.
People with osteoporosis have reduced bone mineral density, which contributes to weaker bones and a greater risk of fractures.
Alendronate helps increase bone mineral density by slowing bone breakdown.
Although the medication does not directly stimulate new bone formation, reducing excessive bone loss allows bone-forming processes to continue while less existing bone is removed.
Over time, this can improve bone mineral density, particularly in the spine and hip.
Supports Calcium Absorption
Vitamin D3, also called cholecalciferol, plays an essential role in maintaining healthy bones.
After entering the body, vitamin D3 undergoes processing in the liver and kidneys to form an active hormone called calcitriol.
Calcitriol helps the intestines absorb calcium and phosphorus from food.
Calcium and phosphorus are essential minerals that help maintain normal bone structure.
When vitamin D levels are inadequate, the body may have difficulty absorbing enough calcium to support healthy bones.
The vitamin D3 component of Fosamax Plus D helps support normal calcium absorption and bone mineralization.
However, Fosamax Plus D alone is not intended to treat established vitamin D deficiency. Additional vitamin D supplementation may be necessary when recommended by your healthcare provider.
Reduces the Risk of Osteoporosis-Related Fractures
Osteoporosis weakens the internal structure of bones, making them more likely to break during falls or everyday activities.
Fractures commonly occur in the hip, spine, and wrist.
By reducing excessive bone breakdown, alendronate helps maintain stronger bones and lower fracture risk.
The vitamin D3 component supports normal calcium metabolism, which is necessary for maintaining healthy bone tissue.
Together, these ingredients help manage osteoporosis through reduced bone loss and improved nutritional support for bone health.
Fosamax Plus D begins affecting bone metabolism after treatment starts, but improvements in bone strength are not immediately noticeable.
Alendronate gradually reduces the activity of osteoclasts, slowing the breakdown of bone tissue.
Changes in bone turnover may occur within the first few months of treatment.
However, measurable improvements in bone mineral density generally take several months to a year or longer.
Because osteoporosis often causes no symptoms until a fracture occurs, you may not feel a noticeable difference while taking the medication.
Your healthcare provider may recommend periodic bone density tests to evaluate your response to treatment.
The length of treatment depends on your fracture risk, bone mineral density, medical history, and response to therapy.
The need for continued bisphosphonate treatment should be reassessed periodically.
Fosamax Plus D is usually taken once weekly, on the same day each week.
Take the tablet first thing in the morning with a full glass of plain water, at least 30 minutes before your first food, beverage, or other medication.
Swallow the tablet whole and remain sitting or standing upright for at least 30 minutes after taking it and until after your first food of the day.
These instructions are important because alendronate may irritate the esophagus if the medication does not pass into the stomach properly.
Do not take Fosamax Plus D at bedtime or before getting out of bed in the morning.
Tell your healthcare provider if you have difficulty swallowing, esophageal disorders, low blood calcium, kidney disease, or a history of significant digestive problems.
Fosamax Plus D helps treat osteoporosis by combining alendronate, which slows bone breakdown, with vitamin D3, which supports calcium absorption. This combination helps increase or maintain bone mineral density and reduce certain fracture risks associated with osteoporosis.
Fosamax Plus D is a prescription medication used to treat osteoporosis in postmenopausal women and men.
Fosamax Plus D contains two active ingredients:
Fosamax Plus D is available as an oral tablet containing 70 mg of alendronate sodium combined with either 2,800 or 5,600 international units (IU) of vitamin D3.
The medication is usually taken once a week, on the same day each week, unless your healthcare provider recommends otherwise.
Fosamax Plus D must be taken on an empty stomach with plain water. Following the correct administration instructions is important because food, beverages, and other medications can significantly reduce the absorption of alendronate.
Improper use may also increase the risk of irritation or injury to the esophagus, the tube that carries food from your mouth to your stomach.
Follow these steps to take Fosamax Plus D correctly and safely:
Always follow your healthcare provider’s instructions. Do not increase your dosage or take additional tablets without medical advice.
Fosamax Plus D is generally prescribed as one tablet taken once weekly.
| Dosage information | General instructions |
| Dosage form | Oral tablet |
| Available strengths | 70 mg alendronate with 2,800 IU or 5,600 IU vitamin D3 |
| Usual dosage | One tablet once weekly |
| When to take | First thing in the morning after getting out of bed |
| How to take | Swallow whole with a full glass of plain water |
| Food and medication spacing | Wait at least 30 minutes |
| Upright position | Remain upright for at least 30 minutes and until after eating breakfast |
Your healthcare provider will determine which strength is appropriate based on your vitamin D needs, osteoporosis treatment plan, and medical history.
Do not take both strengths together unless specifically instructed by your healthcare provider.
Take Fosamax Plus D on an Empty Stomach
Fosamax Plus D must be taken on an empty stomach to allow proper absorption.
Alendronate is poorly absorbed through the digestive system, and food can reduce its absorption even further.
Taking the medication with breakfast, coffee, juice, or other beverages may significantly reduce the amount of alendronate that enters your bloodstream.
This can make the medication less effective at slowing bone loss.
For best results, take Fosamax Plus D immediately after waking up, before consuming anything other than plain water.
Wait at least 30 minutes before eating breakfast or drinking other beverages.
Use Only Plain Water
Always take Fosamax Plus D with a full glass of plain water.
Plain water helps the tablet pass through the esophagus and reach the stomach.
Do not take the medication with mineral water, milk, tea, coffee, or fruit juice.
Certain minerals, particularly calcium, can bind to alendronate and interfere with its absorption.
This reduces the amount of medication available to support bone health.
Avoid taking Fosamax Plus D with a small sip of water. A full glass is recommended to help reduce the risk of the tablet becoming lodged in the esophagus.
Stay Upright for at Least 30 Minutes
After taking Fosamax Plus D, remain sitting, standing, or walking for at least 30 minutes.
Do not lie down, recline in bed, or return to sleep immediately after swallowing the tablet.
Alendronate may irritate the esophagus if the tablet remains in contact with its lining.
Staying upright helps the medication travel into the stomach and lowers the risk of esophageal irritation.
You must also wait until after eating your first food of the day before lying down, even if more than 30 minutes have passed.
If you cannot remain upright for at least 30 minutes, tell your healthcare provider before taking Fosamax Plus D.
Avoid Crushing or Chewing the Tablet
Swallow Fosamax Plus D tablets whole.
Do not crush, chew, split, or suck on the medication.
Alendronate can irritate the tissues of the mouth, throat, and esophagus if the tablet breaks apart before reaching the stomach.
Chewing or allowing the tablet to dissolve in your mouth may increase the risk of painful irritation or ulcers.
If you have difficulty swallowing tablets, tell your healthcare provider.
Do not attempt to modify the tablet without medical advice.
Separate Fosamax Plus D From Other Medications
Certain medications and supplements can interfere with alendronate absorption.
Products containing calcium, magnesium, aluminum, or iron may bind to alendronate in the digestive tract, reducing the amount absorbed.
Examples include calcium supplements, iron supplements, multivitamins, and antacids.
Wait at least 30 minutes after taking Fosamax Plus D before taking other oral medications or supplements.
Your pharmacist may recommend a longer interval for specific products.
If you take several medications each morning, ask your healthcare provider or pharmacist to help you organize a safe dosing schedule.
Do not stop taking your other prescribed medications without medical advice.
If you forget to take your scheduled weekly dose of Fosamax Plus D, take one tablet on the morning after you remember.
Follow the usual instructions by taking it on an empty stomach with a full glass of plain water.
Remain upright for at least 30 minutes and wait until after your first meal before lying down.
After taking the missed dose, return to your original once-weekly schedule on your usual chosen day.
Do not take two Fosamax Plus D tablets on the same day.
Taking extra medication may increase your risk of irritation or injury to the esophagus and other side effects.
If you are unsure when to take your next dose, contact your healthcare provider or pharmacist.Â
The length of treatment depends on your bone mineral density, fracture risk, medical history, and response to the medication.
Fosamax Plus D helps slow bone breakdown and increase bone mineral density over time.
Because osteoporosis develops gradually, improvements in bone strength may take several months or longer.
Your healthcare provider may recommend periodic bone density tests to assess your treatment progress.
The optimal treatment duration has not been established for everyone.
For people with a low risk of fractures, your healthcare provider may consider stopping bisphosphonate treatment after three to five years. People at higher risk of fractures may require continued treatment.
Do not stop taking Fosamax Plus D without consulting your healthcare provider.
Fosamax Plus D can irritate the esophagus and upper digestive tract, particularly if it is taken incorrectly.
Stop taking Fosamax Plus D and contact your healthcare provider promptly if you experience:
Tell your healthcare provider if you have an esophageal disorder, difficulty swallowing, low blood calcium, or kidney problems before starting treatment.
Discuss any calcium or vitamin D supplements you currently use, as your healthcare provider may need to assess your total daily intake.
Taking Fosamax Plus D correctly is essential for safe and effective osteoporosis treatment. Swallowing the tablet with plain water, taking it on an empty stomach, remaining upright, and following a consistent weekly schedule can help improve medication absorption and reduce the risk of esophageal irritation.
Fosamax Plus D (Alendronate/Vitamin D3) is available in the following forms and strength:
Before taking Fosamax Plus D, tell your healthcare provider about any medical conditions, allergies, or medications you are taking.
Fosamax Plus D is a prescription medication used to treat osteoporosis in postmenopausal women and men. It helps slow bone breakdown, increase bone mineral density, and reduce the risk of certain osteoporosis-related fractures.
Fosamax Plus D contains two active ingredients:
Although Fosamax Plus D helps manage osteoporosis, it may cause side effects involving the digestive system, jaw, bones, and mineral balance.
Certain medical conditions, including esophageal disorders, low blood calcium, and severe kidney impairment, may make the medication unsuitable.
Your healthcare provider will review your medical history and determine whether Fosamax Plus D is appropriate for you.
Fosamax Plus D may cause irritation, inflammation, or ulcers in the esophagus.
The esophagus is the tube that carries food and liquids from your mouth to your stomach.
Alendronate can irritate the esophageal lining, particularly if the tablet remains in contact with the tissue for too long.
This may happen when the medication is taken with too little water, swallowed incorrectly, or followed by lying down too soon.
Possible symptoms include:
To reduce the risk of esophageal irritation, take Fosamax Plus D first thing in the morning with a full glass of plain water.
Swallow the tablet whole without crushing, chewing, or sucking on it.
Remain sitting, standing, or walking for at least 30 minutes after taking the medication. Do not lie down until at least 30 minutes have passed and you have eaten your first food of the day.
Fosamax Plus D should not be used by people with certain conditions that delay emptying of the esophagus, such as esophageal strictures or achalasia.
It is also unsuitable for people who cannot remain upright for at least 30 minutes.
Stop taking Fosamax Plus D and contact your healthcare provider promptly if you develop difficulty swallowing, pain when swallowing, chest pain, or new or worsening heartburn.
Fosamax Plus D may rarely cause a serious condition called osteonecrosis of the jaw (ONJ).
Osteonecrosis of the jaw occurs when an area of jawbone becomes damaged and does not heal normally.
In some cases, the affected bone may become exposed inside the mouth.
This condition has been reported in people taking bisphosphonate medications, including alendronate.
Although the risk is low with oral bisphosphonate treatment for osteoporosis, certain factors may increase the likelihood of developing ONJ.
These include poor oral hygiene, dental infections, tooth extractions, invasive dental procedures, cancer, and certain medications that affect bone healing or immune function.
Possible symptoms include:
Tell your healthcare provider and dentist that you are taking Fosamax Plus D before undergoing dental treatment.
Your healthcare provider may recommend a dental examination before starting treatment, particularly if you have risk factors for jaw complications.
Maintain good oral hygiene and attend regular dental appointments.
Do not stop Fosamax Plus D before dental procedures without discussing the risks and benefits with your healthcare provider.
Contact your healthcare provider or dentist promptly if you develop persistent jaw pain, exposed bone, or a mouth wound that does not heal.
Long-term use of bisphosphonate medications, including alendronate, has been associated with rare fractures of the thigh bone.
These are called atypical femoral fractures.
The femur is the large bone extending from the hip to the knee.
Atypical femoral fractures differ from typical osteoporosis-related fractures because they may occur after little or no injury.
In some people, a fracture may develop gradually before the bone breaks completely.
Warning signs may include:
These symptoms may begin weeks or months before a complete fracture occurs.
Not everyone with thigh or groin pain has an atypical fracture. However, new or unexplained pain should be evaluated promptly.
Tell your healthcare provider if you experience persistent thigh, hip, or groin pain while taking Fosamax Plus D.
Your healthcare provider may recommend imaging tests to check for an incomplete fracture.
The need for continued bisphosphonate treatment should be reviewed periodically based on your fracture risk and treatment history.
Fosamax Plus D can affect calcium and phosphate levels in the body.
Calcium and phosphate are essential minerals involved in maintaining strong bones, supporting muscle function, and regulating nerve activity.
Alendronate reduces bone breakdown, which may cause a small decrease in blood calcium and phosphate levels.
In people who already have low blood calcium, this effect may make the condition worse.
Low blood calcium is called hypocalcemia.
Possible symptoms include:
Fosamax Plus D must not be started if you have untreated hypocalcemia. Low blood calcium must be corrected before treatment begins.
The vitamin D3 component helps your body absorb calcium from food.
However, excessive vitamin D intake or certain medical conditions may cause calcium levels to become too high.
High blood calcium is called hypercalcemia.
Possible symptoms include increased thirst, frequent urination, constipation, nausea, and unusual weakness.
People with conditions such as sarcoidosis or certain cancers may be more susceptible to high calcium levels when taking vitamin D.
Your healthcare provider may recommend blood tests to assess calcium, phosphate, and vitamin D levels before or during treatment.
Do not take additional calcium or vitamin D supplements without reviewing your total intake with your healthcare provider.Â
Do not take Fosamax Plus D if you are allergic to alendronate sodium, vitamin D3, or any other ingredient in the medication.
Although allergic reactions are uncommon, some people may develop hypersensitivity to one or more components of the tablet.
Possible symptoms include:
A severe allergic reaction, called anaphylaxis, requires immediate medical attention.
Stop taking Fosamax Plus D and contact your healthcare provider if you develop a suspected allergic reaction.
Seek emergency medical attention immediately if you experience difficulty breathing or swelling of your tongue or throat.
Tell your healthcare provider about any previous allergic reactions to bisphosphonate medications before starting treatment.
Fosamax Plus D should be used with caution in people with kidney disease.
The kidneys help remove alendronate from the bloodstream.
When kidney function is significantly reduced, the body may clear the medication less efficiently.
Fosamax Plus D is not recommended for people with a creatinine clearance below 35 mL/min.
Creatinine clearance is a measurement used to estimate how well the kidneys filter waste products from the blood.
People with mild to moderate kidney impairment may not require a dosage adjustment, but kidney function should be assessed before treatment.
Tell your healthcare provider if you have chronic kidney disease, reduced kidney function, or a history of significant kidney problems.
Your healthcare provider may recommend blood tests to evaluate kidney function and determine whether Fosamax Plus D is suitable.
If you have severe kidney impairment, another osteoporosis medication may be recommended.Â
Tell your healthcare provider if you have liver disease or a history of significant liver problems before taking Fosamax Plus D.
Alendronate is not extensively metabolized by the liver, and the prescribing information does not recommend a specific dosage adjustment for people with liver impairment.
However, the vitamin D3 component requires processing in the liver before it can fully support calcium metabolism.
Certain liver conditions may affect vitamin D processing or absorption.
For example, reduced bile production may interfere with the absorption of vitamin D, which is a fat-soluble vitamin.
People with severe liver disease may also experience vitamin D deficiency or changes in bone metabolism.
Your healthcare provider may assess your vitamin D status and determine whether additional supplementation or monitoring is needed.
Fosamax Plus D is not generally known to cause significant liver injury at recommended doses. Liver disease alone does not automatically prevent its use.
However, your healthcare provider should review your overall medical condition before recommending treatment.Â
Fosamax Plus D is not indicated for use during pregnancy or breastfeeding.
The medication is primarily prescribed to treat osteoporosis in postmenopausal women and men.
Alendronate becomes incorporated into bone tissue and may remain there for an extended period after treatment stops.
Animal studies have raised concerns about potential effects on fetal development, although information from human pregnancies remains limited.
Vitamin D is essential during pregnancy, but the combination of alendronate and vitamin D3 in Fosamax Plus D is not intended for routine prenatal supplementation.
If you become pregnant while taking Fosamax Plus D, stop treatment and contact your healthcare provider.
If you are planning a pregnancy, discuss your treatment history with your healthcare provider before continuing the medication.
It is not known whether alendronate passes into human breast milk. Vitamin D and its metabolites are naturally present in breast milk.
Your healthcare provider will determine whether osteoporosis treatment should be postponed or replaced with a more suitable option during breastfeeding.
Fosamax Plus D may interact with certain medications and supplements.
Some products can reduce the absorption of alendronate, while others may increase the risk of digestive irritation or affect vitamin D metabolism.
Important medication interactions include:
To help prevent absorption problems, take Fosamax Plus D first thing in the morning with plain water.
Wait at least 30 minutes before eating, drinking other beverages, or taking oral medications and supplements. Some medicines may need to be taken at a different time of day.
Tell your healthcare provider or pharmacist about all prescription medications, over-the-counter drugs, vitamins, herbal supplements, and natural health products you take.
Do not start, stop, or change another medication without medical advice.Â
Fosamax Plus D may cause bone, joint, or muscle pain in some people.
Although mild discomfort may occur during treatment, severe pain has also been reported with bisphosphonate medications.
Pain may develop shortly after treatment begins or after several months of use.
Possible symptoms include persistent joint aching, muscle soreness, bone pain, or discomfort that affects normal daily activities.
Tell your healthcare provider if you develop new or worsening pain while taking Fosamax Plus D.
If you experience severe bone, joint, or muscle pain, contact your healthcare provider promptly. Your healthcare provider may recommend stopping the medication and evaluating other treatment options.
Contact your healthcare provider if you experience new or worsening heartburn, stomach pain, difficulty swallowing, jaw discomfort, unusual thigh pain, or persistent muscle cramps.
You should also report any changes in your kidney function, planned dental procedures, or new medications that may interact with Fosamax Plus D.
Stop taking the medication and seek prompt medical evaluation if you develop pain when swallowing, chest pain associated with swallowing, or severe new heartburn.
Seek emergency medical attention if you experience difficulty breathing, swelling of your tongue or throat, severe chest pain, or symptoms of a serious fracture.
Fosamax Plus D helps strengthen bones and reduce fracture risk, but safe administration and regular medical monitoring are important. Taking the medication correctly, maintaining appropriate calcium and vitamin D levels, and reporting unusual symptoms can help reduce treatment-related complications.
The length of treatment with Fosamax Plus D depends on your bone mineral density, risk of fractures, medical history, and response to treatment. Fosamax Plus D is a prescription medication used to treat osteoporosis in postmenopausal women and men. It helps slow bone breakdown, maintain bone strength, and reduce the risk of certain osteoporosis-related fractures. Osteoporosis is a long-term condition that causes bones to become weak and more likely to break. Because bone loss develops gradually, treatment may need to continue for several years. For people with a low risk of fractures, healthcare providers may consider stopping bisphosphonate treatment after three to five years. However, people with a higher fracture risk may need longer treatment. Your healthcare provider may recommend periodic bone density tests to measure your treatment progress and determine whether continued medication is necessary. The optimal treatment duration varies from person to person. Some individuals may be advised to take a temporary break from bisphosphonate treatment, sometimes called a drug holiday, after a careful assessment of their fracture risk. Do not stop taking Fosamax Plus D without consulting your healthcare provider. Stopping treatment without an appropriate plan may leave your osteoporosis inadequately managed.
Yes, Fosamax Plus D can be taken with certain medications, but some drugs and supplements may interfere with its absorption or increase the risk of side effects. Fosamax Plus D contains alendronate sodium, a bisphosphonate that helps slow bone loss, and vitamin D3, which supports calcium absorption. Alendronate is poorly absorbed when taken with food, beverages other than plain water, or certain oral medications. Products containing calcium, magnesium, aluminum, or iron may bind to alendronate in the digestive tract, reducing the amount of medication your body absorbs. Certain medications and supplements require additional precautions when taken with Fosamax Plus D. Calcium supplements, iron supplements, antacids, and multivitamins containing minerals can reduce alendronate absorption if taken too close to your scheduled dose. Nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen, may increase the risk of stomach irritation. Aspirin may also increase gastrointestinal side effects, including stomach pain, heartburn, and discomfort, in some individuals. Your healthcare provider may recommend adjusting when you take these medications to reduce the risk of interactions. To help your body absorb Fosamax Plus D properly, take the tablet first thing in the morning on an empty stomach with a full glass of plain water. Wait at least 30 minutes before eating breakfast, drinking beverages other than water, or taking other oral medications and supplements. Some medications may require a longer interval, so follow your healthcare provider’s instructions. Before starting Fosamax Plus D, tell your healthcare provider or pharmacist about all prescription medications, over-the-counter drugs, vitamins, herbal supplements, and natural health products you use. Your healthcare provider can review your medications, identify possible interactions, and recommend a safe dosing schedule. Do not stop, start, or change any medication without medical advice.
Weight gain is not a commonly reported side effect of Fosamax Plus D. Fosamax Plus D contains alendronate sodium and vitamin D3, which work together to support bone health. Alendronate slows the breakdown of bone tissue, while vitamin D3 helps the body absorb calcium. These ingredients are not generally associated with changes in body weight. However, some people may experience digestive side effects while taking Fosamax Plus D, including abdominal discomfort, nausea, constipation, diarrhea, or bloating. Bloating may temporarily make your stomach feel swollen or full, but this does not necessarily indicate actual weight gain. Changes in body weight may also result from diet, physical activity, fluid retention, other medications, or underlying medical conditions. If you notice unexplained or rapid weight gain while taking Fosamax Plus D, contact your healthcare provider. Your healthcare provider can assess whether the change is related to another medication, medical condition, or lifestyle factor. Do not stop taking Fosamax Plus D solely because of changes in weight without discussing your concerns with your healthcare provider.
Fosamax Plus D is a prescription medication approved to treat osteoporosis in postmenopausal women and increase bone mass in men with osteoporosis. However, it is not specifically approved to prevent osteoporosis in people who have not developed the condition. Osteoporosis occurs when bones gradually lose mineral density, causing them to become weak, fragile, and more likely to break. Fosamax Plus D contains two active ingredients that work together to support bone health. Alendronate sodium is a bisphosphonate that slows the activity of cells responsible for breaking down bone tissue. This helps maintain or increase bone mineral density over time. Vitamin D3 helps the body absorb calcium from food, supporting normal bone development, strength, and mineralization. Together, these ingredients help reduce further bone loss and lower the risk of certain fractures in people who already have osteoporosis. It is important to understand that preventing osteoporosis and treating existing osteoporosis are different medical indications. Certain alendronate-only medications are approved to help prevent osteoporosis in postmenopausal women. However, this preventive indication does not automatically apply to Fosamax Plus D, which is specifically approved for treating existing osteoporosis. To help maintain healthy bones and reduce the risk of developing osteoporosis, your healthcare provider may recommend getting enough calcium and vitamin D, performing regular weight-bearing exercises, maintaining a balanced diet, and avoiding smoking. These measures can help support bone strength and reduce factors that contribute to bone loss. Your healthcare provider may also recommend bone mineral density testing if you have risk factors for osteoporosis, such as increasing age, a family history of fractures, or long-term corticosteroid use. These tests help assess bone strength and identify early signs of bone loss. If you have already been diagnosed with osteoporosis, Fosamax Plus D may help improve bone mineral density, slow further bone loss, and reduce the risk of certain fractures. Your healthcare provider will determine whether Fosamax Plus D is appropriate based on your bone density results, medical history, overall fracture risk, and individual treatment needs.
| Generic name: | Alendronate/Vitamin D3 |
|---|---|
| Formulation: | Tablet |
| Strength(s): | 70mg/2800IU, 70mg/5600IU |
| Quantities Available: | 12 |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
When ordering Fosamax Plus D (alendronate/vitamin D3) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.
Here’s what you need to know:
Dosage and Quantity: Fosamax Plus D is commonly prescribed as one tablet of 70 mg alendronate and 5600 IU vitamin D3, taken once weekly. For a 90-day supply, you would order 12 tablets (1 tablet per week x 12 weeks).
Yes, we sell alendronate/vitamin D3 on our website. You can enjoy low prices when you order through us. To purchase alendronate/vitamin D3, you will need a valid prescription from your healthcare provider. We require this prescription to dispense the medication safely and appropriately. You can submit your prescription by mailing it to us, faxing it, or uploading it through your online account.
Yes, we ship Fosamax Plus D (alendronate/vitamin D3) to both the United States and Puerto Rico.
Watch how Online Pharmacies Canada is helping customers save money on their medications.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Fosamax Plus D (Alendronate/Vitamin D3). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Fosamax Plus D (Alendronate/Vitamin D3).
REVIEWS